4.6 Article

Advancing cardiovascular medicine with machine learning: Progress, potential, and perspective

期刊

CELL REPORTS MEDICINE
卷 3, 期 12, 页码 -

出版社

CELL PRESS
DOI: 10.1016/j.xcrm.2022.100869

关键词

-

资金

  1. General Electric
  2. Janssen Pharmaceuticals
  3. MyoKardia, Inc.

向作者/读者索取更多资源

Recent advances in machine learning have enabled the automated analysis of complex and high-dimensional data in cardiovascular medicine, leading to improved diagnosis, measurement, and prediction capabilities. These advances have significant implications in expanding the utility of diagnostic tests and improving the overall understanding of cardiovascular diseases.
Recent advances in machine learning (ML) have made it possible to analyze high-dimensional and complex data-such as free text, images, waveforms, videos, and sound-in an automated manner by successfully learning complex associations within these data. Cardiovascular medicine is particularly well poised to take advantage of these ML advances, due to the widespread digitization of medical data and the large num-ber of diagnostic tests used to evaluate cardiovascular disease. Various ML approaches have successfully been applied to cardiovascular tests and diseases to automate interpretation, accurately perform measure-ments, and, in some cases, predict novel diagnoses from less invasive tests, effectively expanding the utility of more widely accessible diagnostic tests. Here, we present examples of some impactful advances in car-diovascular medicine using ML across a variety of modalities, with a focus on deep learning applications.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据